PhD Nataša Resnik
no.: 28393

researcher – active in research organisation

Research activity

Code	Science	Field	Subfield
1.05.00	Natural sciences and mathematics	Biochemistry and molecular biology
3.03.00	Medical sciences	Neurobiology

Bibliography Representative bibliographic units | Personal| COBISS+

source: COBISS

source: SICRIS

Evaluation (rules)

Evaluation of bibliographic research performance indicators according to ARIS methodology

source: COBISS

source: ARIS

Points

244.73

A''

71.92

A'

121.37

A1/2

173.02

CI10

321

CImax

49

h10

12

A1

0.9

A3

0

Data for the last 5 years (citations for the last 10 years) on April 30, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)

Data for ARIS tenders ( 12.01.2024 – Project tender, archive )

Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases

source: WoS

source: Scopus

source: COBISS

Database	Linked records	Citations	Pure citations	Average pure citations
WoS	27	462	302	11.19
Scopus	27	509	341	12.63

Doctoral dissertations and other final papers Show

source: COBISS

Employments

source: ARIS

Type of employment	Research org.	Research group
Full time employment (120%, RD:22%)	University of Ljubljana, Faculty of Medicine	Institute of Cell Biology

Research projects Legend

source: ARIS

no.	Code	Title	Period	Head	No. of publications
1.	J4-50147	Exploring the theranostic potential of aegerolysin-based protein complexes in combating bladder cancer	2023 - 2024	PhD Kristina Sepčić	3,713
2.	J2-3046	Selective electroporation by distributed nanoelectrodes	2022 - 2024	PhD Damijan Miklavčič	3,374
3.	J2-3043	Exploitation of the magneto-mechanical effect in the treatment of neurodegenerative diseases	2021 - 2024	PhD Slavko Kralj	4,406
4.	J2-2487	Bioactive, in situ modified, fibrous membranes based on bacterial cellulose: processing, characterisation and assessment of biomedical potential	2020 - 2024	PhD Selestina Gorgieva	2,763
5.	J3-2526	Unravelling glioma stem cell niches for novel therapeutic targets in glioblastoma patients	2022 - 2023	PhD Cornelis J.F. van Noorden	2,318
6.	J3-2521	Inflammatory process in interstitial cystitis and evaluation of the influence of cannabinoid receptor agonists in urinary bladder - from cells to patients	2020 - 2023	PhD Peter Veranič	3,823
7.	J7-2594	The amniotic membrane as a novel multimodal therapy for bacterial cystitis and bladder cancer: unravelling its antimicrobial, immunomodulatory and anticancer activity	2020 - 2023	PhD Mateja Erdani Kreft	5,134
8.	J1-9162	Neurotoxicity or neuroprotection of nanomaterials: the rele of biocorona	2018 - 2022	PhD Damjana Drobne	5,206
9.	J3-9255	Evaluation of viral protein Nef induced extracellular vesicles as plasma biomarker of leaky HIV-1 reservoir in aviremic adults	2018 - 2021	PhD Metka Lenassi	2,456
10.	J4-7162	Applications of aegerolysin-like proteins for detection and eradication of pests	2018	PhD Kristina Sepčić	5,150
11.	J3-7494	Tunneling nanotubes for innovative urinary bladder cancer treatments	2017 - 2018	PhD Mateja Erdani Kreft	7,082
12.	J1-4305	Molecular Description of Lipid Membrane Changes in Disease	2011	PhD Gregor Anderluh	4,775

ARIS research and infrastructure programmes Legend

source: ARIS

no.	Code	Title	Period	Head	No. of publications
1.	P3-0108	Differentiation of urothelial cells	2018 - 2024	PhD Rok Romih	1,414
2.	I0-0022	Mreža raziskovalnih infrastrukturnih centrov Univerze v Ljubljani (MRIC UL) (Slovene)	2020	PhD Anton Ramšak	13,483
3.	P3-0108	Differentiation of urothelial cells	2014 - 2017	PhD Rok Romih	1,501
4.	P3-0108	Differentiation of urothelial cell	2009 - 2013	PhD Rok Romih	1,299

We were not given permission by the researcher to publish data.